跳至主要内容
临床试验/EUCTR2009-016241-25-GR
EUCTR2009-016241-25-GR进行中(未招募)不适用

MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO DEMONSTRATE THE SAFETY AND EFFICACY OF THE THERAPY WITH THE COMBINATION ERYTHROMYCIN-ISOTRETINOIN/VERISFIELD, GEL, (2.0+0.05)% W/W FOR THE TOPICAL TREATMENT OF MILD TO MODERATE ACNE

VERISFIELD (UK) LTD, GREEK BRANCH0 个研究点开始时间: 2010年4月19日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - PATIENTS WITH MILD TO MODERATE ACNE (ACNE VULGARIS)
  • - MALE AND FEMALE PATIENTS AGED 12-35 YEARS
  • - MALES AND FEMALES WHO ARE CONSIDERED HEALTHY
  • - FEMALE PATIENTS WHO DO NOT MANIFEST ANY SIGNS OF HYPERANDROGENISM
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - PATIENTS WHO HAVE PARTICIPATED OR CURRENTLY PARTICIPATING IN ANOTHER STUDY
  • - PATIENTS ON TOPICAL OR SYSTEMIC TREATMENT FOR ACNE
  • - PATIENTS WHO RECEIVE DRUGS THAT MIGHT INFLUENCE THE FINDINGS OF THE STUDY
  • - PATIENTS WITH CARDIOVASCULAR, NEOPLASMIC, HAEMATOLOGICAL, HEPATIC, RENAL, NEUROLOGICAL, ENDOCRINE AND GASTROENTEROLOGICAL DISEASE
  • - PATIENTS WITH A DERMATOLOGICAL LESION IN THE AREA (OR IN CLOSE PROXIMITY e.g. 3cm) TO BE TREATED
  • - PREGNANT OR LACTATING PATIENTS
  • -FEMALE PATIENTS IN REPRODUCTIVE AGE WHO DO NOT RECEIVE ADEQUATE CONTRACEPTION

研究者

发起方
VERISFIELD (UK) LTD, GREEK BRANCH

相似试验

进行中(未招募)
不适用
MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE STUDY WITH THE REFERENCE PRODUCTS, FOR ASSESSMENT OF THERAPEUTIC SUPERIORITY OF THE COMBINATION CLINDAMYCIN-TRETINOIN/VERISFIELD, GEL, (1.0+0.025)%, (VERSUS THE MONOTHERAPY WITH CLINDAMYCIN OR TRETINOIN) FOR THE TOPICAL TREATMENT OF ACNEACNE (ACNE VULGARIS)
EUCTR2009-017201-11-GRVERISFIELD (UK) LTD, GREEK BRANCH
进行中(未招募)
不适用
MULTICENTER, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE THERAPY WITH THE COMBINATION OF BENZOYL PEROXIDE-ERYTHROMYCIN/VERISFIELD, GEL, (5+3)% W/W FOR THE TOPICAL TREATMENT OF ACNE VULGARIS
EUCTR2009-016240-40-GRVERISFIELD (UK) LTD, GREEK BRANCH
已完成
不适用
COMPARATIVE, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-MASKED STUDY OF AZITROMYCIN SR VERSUS LEVOFLOXACIN FOR THE TREATMENT OF PNEUMONIA ACQUIRED IN THE MILD TO MODERATE COMMUNITY IN ADULTS-J159 Bacterial pneumonia, unspecifiedBacterial pneumonia, unspecifiedJ159
PER-023-03PFIZER S.A.,
已完成
不适用
RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC COMPARATIVE STUDY, PHASE III, WITH TWO COURSES OF DIFFERENT THERAPY WITH BMS-284756 ORAL VS AMOXICILLINE / ORAL CLAVULANATE IN THE TREATMENT OF ACUTE SINUSITIS
PER-054-01BRISTOL MYERS SQUIBB PERU S.A.,
已完成
不适用
COMPARATIVE, MULTICENTER, DOUBLE-BLIND, RANDOMIZED STUDY OF RIFAXIMIN VS CYPROFLOXACIN (CIPRO®) IN THE TREATMENT OF DISEASE DIAPEREA CAUSED BY ENTEROPATHOGENIC ORGANISMS-A04 Other bacterial intestinal infectionsOther bacterial intestinal infectionsA04
PER-055-02IVERSIDAD PERUANA CAYETANO HEREDIA,